SCHEMBL16239187

SCHEMBL16239187

O=C(O)NCCNc1ccc2ccccc2c1[N+](=O)[O-]

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
TSHR P16473 1/20 0.49
CA12 O43570 1/20 0.47
CA4 P22748 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
NCEH1 Q6PIU2 1/20 0.45
CYP3A4 P08684 1/20 0.43
MAPT P10636 6/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
KDM4E B2RXH2 3/20 0.41
KAT2B Q92831 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8671420 0.85 ALDH1A1 (0.52) HSP90AA1CRHBPCRHR2TSHRNCEH1
SCHEMBL8609981 0.82 HSP90AA1 (0.49) HSP90AA1CRHBPCRHR2TSHRNCEH1
SCHEMBL29908861 0.82 BCHE (0.46) HSP90AA1CRHBPCRHR2TSHRCA12
SCHEMBL7484286 0.79 TOP2A (0.52) HSP90AA1CRHBPCRHR2TSHRNCEH1
SCHEMBL27972555 0.79 NCEH1 (0.45) HSP90AA1CRHBPCRHR2TSHRCA12
SCHEMBL16239118 0.78 CA12 (0.51) TSHRCA12CA4CA7CA9
SCHEMBL11889090 0.78 CA12 (0.51) TSHRCA12CA4CA7CA9
SCHEMBL17883919 0.77 NCEH1 (0.45) HSP90AA1CRHBPCRHR2TSHRCA12
SCHEMBL17819091 0.77 CNR1 (0.52) HSP90AA1CRHBPCRHR2TSHRNCEH1
SCHEMBL3655465 0.77 CA12 (0.74) TSHRCA12CA4CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434207-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2022-09-06 US disclosed
CN-108863959-B P2X4 receptor antagonists 日本化学药品株式会社 2021-11-30 CN disclosed
US-20200223806-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2020-07-16 US disclosed
CN-111333588-A P2X4 receptor antagonists 日本化学药品株式会社 2020-06-26 CN disclosed
US-10633349-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2020-04-28 US disclosed
CN-104066724-B P2X4 receptor antagonists 日本化学药品株式会社 2020-04-17 CN disclosed
US-20180201587-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2018-07-19 US disclosed
US-9969700-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD. (JP) 2018-05-15 US disclosed
EP-2803662-B1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO (JP) 2017-03-01 EP disclosed
US-20160280667-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2016-09-29 US disclosed
US-20140357858-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2014-12-04 US disclosed
EP-2803662-A1 P2X4 RECEPTOR ANTAGONIST Nippon Chemiphar Co., Ltd. (JP) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280667-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 HSP90AA1 3923/4885CRHBP 1032/4885CRHR2 332/4885
US-20140357858-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 HSP90AA1 3933/4885CRHBP 1095/4885CRHR2 349/4885
US-20200223806-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 HSP90AA1 3933/4885CRHBP 1095/4885CRHR2 349/4885
US-11434207-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 HSP90AA1 3933/4885CRHBP 1095/4885CRHR2 349/4885
US-10633349-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 HSP90AA1 3933/4885CRHBP 1095/4885CRHR2 349/4885
US-20180201587-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 HSP90AA1 3933/4885CRHBP 1095/4885CRHR2 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.